Early trial tests stem cell particles for rare Muscle-Weakening disorder

NCT ID NCT07226726

Recruiting now Disease control Sponsor: The Foundation for Orthopaedics and Regenerative Medicine Source: ClinicalTrials.gov ↗

Summary

This early-stage study is testing whether exosomes (tiny particles released from stem cells) can help treat congenital myasthenic syndrome, a rare genetic disorder that causes muscle weakness. The trial will involve 20 participants who will receive the experimental treatment and then be monitored for changes. Researchers will track outcomes like oxygen levels to see if the treatment is safe and potentially helpful.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CONGENITAL MYASTHENIC SYNDROME are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Medical Surgical Associates Center
RECRUITING

St John's, Antigua and Barbuda

Contact Phone: •••-•••-•••• Email: •••••@•••••
Prodromos Stem Cell Institute
RECRUITING

Naples, Florida, 34102, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Prodromos Stem Cell Institute
RECRUITING

Irving, Texas, 75039, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

CONGENITAL MYASTHENIC SYNDROME